Try our Advanced Search for more refined results
Life Sciences - December, 2023
260 articles
- Apple Watch Import Ban Put On Hold By Fed. Circ.
- White House Won't Veto ITC Apple Watch Import Ban
- Crowell & Moring Reaches Deal In Walgreens-Humana Conflict
- Investor Sues Illumina, Ex-Execs Over Unwound Grail Deal
- The Most-Read Legal Industry Law360 Guest Articles Of 2023
- Covington-Led Bristol Myers To Buy Karuna In $14B Deal
- The 5 Biggest First Circuit Rulings Of 2023
- GSK, Kaleo Scale Back Orange Book IP In FTC Campaign
- Becton Investors Seek OK Of $85M Deal Over Alaris Recall
- Alexion 'Misled' USPTO About Blood Drug Patent, PTAB Says
- HHS Seeks Early Win Defending Medicare Drug Price Program
- Judge Asked To Double $31M Genetic Testing Verdict
- FTC, DOJ End 2023 With New Guidance, Lingering Challenges
- Inside Higher Education's New FCA Liability Challenges
- J&J Consumers' Adviser Keeps Bonus Pay In Talc Unit Ch. 11
- AI Executive Order's Life Science, Healthcare Industry Effects
- 5 Most Notable Class Action Standing Cases Of 2023
- NJ Court Won't Rethink Quashing J&J's Law Firm Subpoenas
- HHS Advisory Highlights Free Product Inducement Risks
- Haynes Boone Hires Rothwell Figg Life Sciences Counsel
- Attorneys' Busiest Times Can Be Business Opportunities
- Exxon, Chevron Top 2023's 10 Largest M&A Deals
- 2024 Trends To Watch As AI And IP Litigation Intersect
- Top Connecticut Cases Of 2023
- 11 Deals That Shaped Healthcare And Life Sciences In 2023
- Beasley Allen Atty Slams J&J's 'Locker-Room Brawl' DQ Bid
- Medical Device Cos. Settle Trade Secrets Suit For $8M
- Top Product Liability Cases Of 2023
- ITC Rejects Apple's Bid To Put Apple Watch Ban On Hold
- FDA Offers Guide On Real-World Data For Device Submissions
- Biochemical Co. Amyris OK'd To Sell Celebrity Brands
- The Top Bankruptcy Cases And Issues Of 2023
- FDA Drops List Of Off-Patent Drugs Without Approved Generic
- 9th Circ. Scienter Ruling May Strengthen FDA's Leverage
- SomaLogic Founder Sues In Del. Chancery To Block $1B Deal
- No Discovery In Regeneron FCA Case Until 1st Circ. Rules
- In The World Of Legal Ethics, 10 Trends To Note From 2023
- Fed. Circ. Won't Touch Hypertension Drug Patent Ruling
- Stimwave Buyer Can Enforce Sale In 'Disturbing' Domain Row
- Choppy Conditions Tripped Up Capital Markets Again In 2023
- Pharma Co. Impel Hits Ch. 11 With $127M Debt And Sale Plans
- Cannabis Co. Urges Judge To Deny Win In IP Row
- AmerisourceBergen Ruling Sharpens Del.'s Compliance Focus
- Indicted Stimwave CEO Hit With $41M Civil Suit From SEC
- Invisalign Fights Social Media Class Notice In Antitrust Suits
- All 5 Of Plaintiffs' Expert Witnesses Barred In Tylenol MDL
- Doctor Groups Say Ark. Law Blocks Lifesaving Gender Care
- Anesthesiologists Say CMS Reimbursement Math Is Unlawful
- Swiss Hearing Implant Co. Lands $1.4M Patent Verdict In Del.
- Bradley Adds Healthcare, Real Estate Attys To Nashville Office
- The States That Legalized Pot In 2023, And One That Didn't
- Acadia Investor Says Officers Overhyped Drug's Prospects
- Philips Unit Inks $14.7M FCA Deal For Cardiac Monitoring Bills
- What China's New Rare Disease Catalog Means For Drug Cos.
- 9th Circ. Panel Reverses Man's Disability Coverage Denial
- Emcure Seeks Fees After $950M Vax Trade Secrets Suit Nixed
- How Attorneys Can Be More Efficient This Holiday Season
- Zymergen Gets Conditional OK For Ch. 11 Asset Sales
- 2nd Trader Avoids Prison In Covington Info Theft Case
- The Biggest PTAB Developments In 2023
- Steward Health Paid Boston Cardiac Doc Kickbacks, Feds Say
- Del. Justices Reverse Chancery AmerisourceBergen Suit Toss
- Olympics Track Coaches Charged In NY With Doping Athletes
- HHS Says Chambers Have No Place In Drug Price Dispute
- SC Judge Won't Reconsider Foam Co. Dismissal Ruling
- Fed. Circ. Sends Philips' Row With Fitbit Back To Lower Court
- 'Superb' Juul MDL Attys Get $76.5M, But Diversity Issue Noted
- Life Sciences Co. Sells Its Spine Biz To H.I.G. In $375M Deal
- Judge Partially Tosses Texas Suit Over Failed Gov't Contract
- Stimwave Buyer Pans Ex-CEO's 'Nonsensical' Domain Claim
- Feds Defend Chevron Deference In Second High Court Case
- Catching Up With Delaware's Chancery Court
- 3 Defense Takeaways From The Bankman-Fried Trial
- Apple To Halt Apple Watch Sales Due To Masimo Patent Case
- Children's Book Writing Makes Me A Better Lawyer
- 5th Circ. Says FTC Must Reconsider $8B Illumina-Grail Merger
- DOJ Slams Teva's Bid For Answers On Dropped Case
- IPOs In 2024 Will Be Invite-Only, Life Sciences Insiders Say
- Feds Urge 8th Circ. To Affirm Block On Ark. Trans Care Ban
- Patent Office Says Double Patenting Ruling Was 'Textbook'
- Artis Ventures Closes $200M Fund For TechBio Investments
- Autism Care Provider Gets 366-Day Term For Medicaid Fraud
- Zymergen Names 2 Successful Bidders In Ch. 11 Auction
- Amyris Says DIP Lender Will Bid For Remaining Assets
- Amendment Sinks Ohio AG's Bid To Resume Abortion Limits
- Boston Scientific Reaches $38.5M Deal To End Investor Suit
- How The PTAB Landscape Shifted In 2023
- New Pharma Guidelines Bring Pitfalls For Compounders
- MSU Reverses Stance, Agrees To Release Nassar Documents
- What Happens If High Court Rejects Releases In Purdue Ch. 11
- Exec's Parents Say Examiner Botched Autopsy, Leaked Info
- Motley Rice 'Weaponized' Gov. Info For Opioid MDL, PBM Says
- Taxation With Representation: Latham, Freshfields, Debevoise
- 1st Circ. Backs Off-Label Marketing Convictions
- Acadia Drug Patent Survives Attack In MSN Case
- IP Forecast: Del. Judge To Hear Kidney Drug Case
- Ohio Clinics Double Down On Suit Over 6-Week Abortion Ban
- Feds Seek Up To 2 Years For Merck Merger Tippee
- Judge Divvies Up Atty Fees From $785M FCA Deal
- Mass. Pharmaceutical Co. Banned From Making Drugs
- Shkreli's Lifetime Pharma Ban Goes Too Far, 2nd Circ. Told
- FDA's Recent Litigation Records Are Strong, But Imperfect
- Jury Finds No Infringement Of Spinal Implant Patents
- Coming To Terms With Means-Plus-Function Patent Claims
- FDA Seized $18M Worth Of Imported Vapes At LA Airport
- Del. Justices Spike EpicentRx Appeal For Target Co. Docs
- Fed. Circ. Backs Rejection Of Institut Pasteur's Patent App
- Harvard Doctor Secretly Impregnated Me In 1980, Patient Says
- A Look Back At The Abortion Battles Of 2023
- Military Health System Lacks Opioid Rx Controls, IG Finds
- 5 Steps For Healthcare Companies After Biden's AI Order
- Giving The Gov't Drug Patent March-In Authority Is Bad Policy
- The Biggest Patent Rulings Of 2023
- The Biggest Legal Ethics Cases Of 2023
- Split 11th Circ. Panel Backs Walgreens Defeat Of FMLA Suit
- Jazz, Express Scripts Beat Calif. Overcharge Suit, For Now
- EU OKs $22B Bioscience Cos. Merger After Remedies
- 6 Biggest Healthcare Fraud Cases Of 2023
- Verve Motion Scores $20M In Series B Round
- Morgan Lewis Guides Integra On $275M Pharma Biz Deal
- How Clients May Use AI To Monitor Attorneys
- DEA Must Consult FDA On Psilocybin Petition, 9th Circ. Told
- Supreme Court To Consider Fight Over Abortion Medication
- Sidley Hired For HeadFirst's £483M Bid For Recruiter Impellam
- Revolution Beauty Settles With Ex-Chair Over £28M Deal
- AstraZeneca Urges Chancery To Toss $3B Viela Bio Sale Suit
- Longhorn Points Finger At Ex-Counsel After PTAB Sanctions
- Whistleblower Says Allergan Knowingly Overbilled Medicaid
- 7 Enforcement Predictions For US Export Controls, Sanctions
- Novartis To Pay Daiichi $182M In Deal To End Appeal
- NYC Leader Of Black-Market HIV Drug Scheme Pleads Guilty
- Senate Health Panel OKs Bipartisan Opioid Treatment Measure
- Quinn Emanuel Escapes Drug Pricing Antitrust Subpoena
- Amyris Gets OK To Solicit Ch. 11 Plan Votes
- Paul Weiss M&A Counsel Shifts Practice To Goodwin In NY
- Freshfields-Led AstraZeneca To Buy Vaccine Maker For $1.1B
- Sanofi Scraps $755M Licensing Deal Amid FTC Challenge
- Patent Deals Don't Support $410M DNA Test Suit, Court Told
- Texas High Court Revokes Order Allowing Emergency Abortion
- Chamber Finds Drug Price Measures Will Stifle Research
- House Passes Healthcare Pricing Transparency Bill
- Healthcare-Focused SPAC Gardiner Acquisition Calls It Quits
- Eli Lilly Must Face Most Claims In Diabetes Medication Suit
- Amyris Creditors Slam 'Tainted' Ch. 11 Plan
- One Natera Patent Falls, But Others Survive
- Moderna Says Pfizer COVID Vax Patent Challenges Fail Fintiv
- Kaiser Beneficiaries Win Class Cert. In Discrimination Suit
- Conn. Seeks Default, Contempt In $10.9M Drug Kickback Case
- Novo Nordisk Says Fed Drug Pricing Unseen Even In Wartime
- Kristen Bell's Baby Co. Gets OK For $65M Ch. 11 Sale
- Biden Would Veto Rulemaking Bill Citing 'Unnecessary Delays'
- How AI Executive Order Aims To Compete For Foreign Talent
- Medtronic Says Promotions Not Basis For FCA Case
- ESG Around The World: Singapore
- Sanofi Tells 3rd Circ. Post-Ch. 11 Drug Sales Triggered Deal
- Top Court Won't Hear Hedge Fund Priest's Appeal In SEC Case
- Mich. AG Asks 6th Circ. To Deny Christian Health Clinic Appeal
- Scrubs Co. Sues Attys Over Fees In Lost False Ad Suit
- The Pop Culture Docket: Judge D'Emic On Moby Grape
- Catching Up With Delaware's Chancery Court
- Navigating Asset Tracing Challenges In Bankruptcy
- Jury Frees Abbott Labs From Sales Exec's Age Bias Suit
- Cigna Opts For $10B Buyback As Humana Deal Rumors Fizzle
- High Court Won't Review CoolSculpting Warning Suit
- Texas High Court Halts Order Granting Emergency Abortion
- Circuit-By-Circuit Guide To 2023's Most Memorable Moments
- New Drug Patent Proposal Sparks Worry Over Gov't Overstep
- Carriers Urge Pa. Justices To Flip Policyholder Pandemic Win
- JPML Moves Actions On Ineffective Decongestants To NY
- Ex-CEO Admits Securities Fraud In Fake COVID Test Case
- SC Argues With 4th Circ. Over Right To Sue Under Medicaid
- Barnes & Thornburg Adds Healthcare Atty From Krieg DeVault
- Reading The Fine Print On FDA's Prescription Drug Ad Rule
- Magistrate Pans Countersuit To Rwanda's $40M Fraud Claim
- Biomedical Cos. Score $62M Award In Trade Secrets Trial
- Novo Nordisk Must Face Bulk Of Woman's Ozempic Injury Suit
- Perils Of Incorporation By Reference At The Federal Circuit
- J&J Hit With Suit Over Stelara Exclusivity
- UK Litigation Roundup: Here's What You Missed In London
- US Glycine Co. Rips Commerce's Refusal To Expand Duties
- Performing Music Makes Me A Better Lawyer
- Generics Price-Fixing Cases Should Stay In MDL, Judge Says
- Gilead Sued In Calif. Over Remdesivir COVID-19 Claims
- 6th Circ. Judge Doubts Error In Tossing Diabetes Drug MDL
- Teva Says EpiPen Suit Only Remedy For Colo. Takings
- Fed. Circ. OKs Mixed Ruling For Lundbeck In Trintellix IP Case
- Congress Members Pitch Bill Letting States Set Pot Policy
- Feds Say Lack Of Funding, Officers Fueling Native Drug Crisis
- Pfizer Unit Agrees To Construct Floodplain At Superfund Site
- 'Patient' Definition Ruling Raises Discount Drug Questions
- Texas Judge Says Woman Can Get Abortion Despite State Ban
- Amyris Files Ch. 11 Plan With $23M Creditor Deal
- Biden Admin Looks To Take Over Expensive Drug Patents
- Wellness or Medical? Device-Maker Attys Look for Answers
- Cancer Test Co. Overpromised Insurer Coverage, Suit Says
- Cooley Atty Can't Ax 'Rather Harsh' Sanctions, 3rd Circ. Says
- Fed. Circ. Wrestles With Apple Bid To Ax More Masimo Patents
- Ex-USPTO Directors Rally Against WTO IP Waiver
- Boston Biotech Seeks $716K For COVID-19 Test Default
- Patent Suit Deal Sounds Like 'Money Laundering' To Judge
- Kirkland-Led AbbVie To Pay $8.7B For Cerevel Therapeutics
- Tech Players Square Off In $4M Fight Over Penthouse Elevator
- Apple Allowed To Seal Smartwatch Competition Hearing
- CVS Hit With Class Action Following Eye Drop Recall
- Breaking Down High Court's New Code Of Conduct
- Judge Orders 3 Case Tracks, Appoints Counsel In Insulin MDL
- Philips Settles Claim Rival's Worker Hacked Ultrasound Tech
- Ex-CEOs Must Face Claims They Pilfered Bioscience Co.'s IP
- Patent Board Says Goodnight To NYU's Sleep Machine Patents
- Texas Sued By Pregnant Woman Seeking Abortion Care
- Group Says US Gov't Must Address Drug 'Patent Thickets'
- Abbott Labs Says Sales Exec Fired Due To Attitude, Not Age
- Mintz Bolsters Healthcare Practice With Wiley Partner
- Ex-Hospital CFO, 3 Doctors Settle Kickback Case For $880K
- How Purdue High Court Case Will Shape Ch. 11 Mass Injury
- Senators Debate Reimbursement Ideas To Fix Drug Shortages
- Bristol-Myers Decries Blue Cross Unit's Last-Minute Dropout
- Court Denies Duty-Free Treatment For Specialty Baby Formulas
- PTAB To Eye Hormone Drug Again In Patent Fight
- Drug Co. Aceragen OK'd For Chancery-Overseen Liquidation
- Legal Profession Gender Parity Requires Equal Parental Leave
- PacBio Sees Most Of Its In-House Legal Dept. DQ'd In IP Row
- Tenn. Seeks To Bar HHS Title X Denial Over Abortion Stance
- Pa. Court Told Overdose Prevention Org. Has Religious Views
- Fed. Circ. Not Sure It Should Answer PREP Immunity Question
- Wash. Judge Nixes HDT's $950M mRNA Vax Trade Secrets Suit
- Dickinson Wright Adds Lewis Brisbois IP Atty In Denver
- Seagen Looks To Revive Cancer Drug Claims In Daiichi Fight
- Leave The Courtroom Doors Open, Says Apple Foe
- Justice Jackson Skeptical Of Sacklers' Ch. 11 Liability Shield
- Parents Want Abbott Docs On Calif. Law In Baby Formula MDL
- Justices Take Cautious Look At Sacklers' Purdue Immunity
- AstraZeneca Criticizes HHS For Bid To Skirt Drug Price Suit
- Pharma Heirs Owe $5.4M In Tax On Merger, Tax Court Says
- Ex-FBI Trainee Cops To Trading On Covington Insider Info
- Clinical Lab Group Slams FDA Proposal To Regulate Lab Tests
- Pear Therapeutics Seeks WARN Act Class Suit Settlement
- Kristen Bell's Baby Co. Eyes $65M Early-Bidder Ch. 11 Sale
- J&J, Ethicon Settle 224 Hernia Mesh Defect Suits In MDL
- Catching Up With Delaware's Chancery Court
- Sidley-Led Roche To Buy US Drugmaker For Up To $3.1B
- Justices Call O'Connor 'American Hero,' 'Perfect Trailblazer'
- Natera Wins Cancer Test Injunction After $19M IP Verdict
- Former Clerks Say Justice O'Connor Still Worth Emulating
- Voters Worried About Health Care Affordability, Poll Shows
- Up Next At High Court: Purdue Pharma, Taxes & Job Transfers
- La. Lab Owner Indicted For $148M Urine Test Billing Scheme
- Congress Has Chance To Adjust Hemp Policy, Report Says
- Med Tech Co. Sues AI Maker Over Use Of 'Judi' Mark
- Mass. Lab Execs Guilty Of Bloodwork Kickback Conspiracy
- Clinic Owner, Pharma Tech Sentenced For Fake Clinical Trial
- Leases Don't Disqualify Small Biz Bankruptcies, Court Rules
- Xencor Scoffs At USPTO Bid To Send Case To Review Panel
- J&J MedTech Buys Heart Device Maker Laminar In $400M Deal
- Managing ANDA Venue Issues As Del. And NJ Filings Rise
- Purdue's High Court Case Puts Bankruptcy Pragmatism On Trial
- 4 Decisions For Which Justice O'Connor Will Be Remembered
- Justice O'Connor Shattered Barriers, Built Bridges
- Sandra Day O'Connor, First Woman On Supreme Court, Dies
- Writing Thriller Novels Makes Me A Better Lawyer